UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000011473
Receipt number	R000013428
Scientific Title	Phase II study of erlotinib monotherapy for patients with untreated advanced non-small cell lung cancer, poor performance status and positive EGFR mutation status (OSAKA-LCSG1304)
Date of disclosure of the study information	2013/08/27
Last modified on	2015/06/30 15:16:36

---